Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

BRCA1/2 Mutation × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2774 Neoplasms 2245 Carcinoma, Non-Small-Cell Lung 1689 Prostatic Neoplasms 1510 Colorectal Neoplasms 1233 Lung Neoplasms 1151 Multiple Myeloma 852 Neoplasm Metastasis 827 Leukemia, Myeloid, Acute 795 Pancreatic Neoplasms 771 Ovarian Neoplasms 726 Melanoma 712 Carcinoma, Hepatocellular 663 Recurrence 584 Brain Neoplasms 579 Stomach Neoplasms 575 Squamous Cell Carcinoma of Head and Neck 575 Head and Neck Neoplasms 518 Lymphoma 501 Glioblastoma 501 Uterine Cervical Neoplasms 482 Precursor Cell Lymphoblastic Leukemia-Lymphoma 473 Carcinoma, Renal Cell 457 Triple Negative Breast Neoplasms 448 Endometrial Neoplasms 428 Colonic Neoplasms 420 Urinary Bladder Neoplasms 417 Hematologic Neoplasms 412 Lymphoma, Non-Hodgkin 400 Sarcoma 387

Interventions

rocakinogene sifuplasmid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04367675 2026-02-23

INO 5401 Vaccination in BRCA1/2 Mutation Carriers

Abramson Cancer Center at Penn Medicine

Phase 1 Active not recruiting

BRCA1/2 Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡